Convatec Group (FRA:2CVU) Inventories, Work In Process: €44 Mil (As of Dec. 2025)


FRA:2CVU Convatec Group PLC FRA:2CVU
77 GF Score
Price €9.80
GF Value €11.81
! 4 Warning Signs
View Full Analysis

What is Convatec Group Inventories, Work In Process?

Convatec Group FRA:2CVU 77 Inventories, Work In Process is €44 Mil as of Dec. 2025. GuruFocus rates FRA:2CVU with a GF Score™ of 77/100 and a GF Value™ of €11.81. The stock has 4 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Convatec Group's work in process for the quarter that ended in Dec. 2025 was €44 Mil.

Convatec Group Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Convatec Group's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Convatec Group Inventories, Work In Process Chart

Convatec Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.54 39.27 38.97 30.56 43.55

Convatec Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.97 0.00 30.56 0.00 43.55
FRA:2CVU
77GF Score
Convatec Group PLC FRA:2CVU
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Convatec Group Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €44 Mil mean?
Convatec Group (FRA:2CVU) has a Inventories, Work In Process of €44 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Convatec Group and its competitors.
Is Convatec Group's Inventories, Work In Process too high?
Convatec Group's current Inventories, Work In Process is €44 Mil. Overall, Convatec Group has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Inventories, Work In Process compare to ISRG and BDX?
Convatec Group's Inventories, Work In Process of €44 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Convatec Group and its competitors. Convatec Group's current Inventories, Work In Process is €44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Convatec Group (FRA:2CVU) has a current Inventories, Work In Process of €44 Mil. The stock's GF Value™ is €11.81, compared to a current price of €9.80 — trading 17% below its estimated fair value. The current Inventories, Work In Process is €44 Mil. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Convatec Group (FRA:2CVU), the current Inventories, Work In Process is €44 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (FRA:2CVU) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of €9.80 is trading 17% below its estimated GF Value™ of €11.81.

Key valuation signals for FRA:2CVU:

  • Inventories, Work In Process: €44 Mil
  • GF Value™: €11.81 vs. price of €9.80 (17% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the FRA:2CVU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for FRA:2CVU

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.80
Price
€11.81
GF Value